Clinical Trial Update: Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at MD Anderson Cancer Center is studying whether modifying the gut microbiome via fecal transplantation can reduce medication-related g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis
• Cutaneous Melanoma
• Genitourinary Cancers
• Non-small Cell Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Phase 1 | Status: RECRUITING